New stock news | Haitong Energy Saving, Shima Pharmaceutical, and other companies planning to launch IPOs on the Hong Kong Stock Exchange have already submitted application materials to the China Securities Regulatory Commission.

On November 21, the China Securities Regulatory Commission released a table of domestic enterprises' overseas issuance of securities and listing filing status (initial public offering and full circulation) (as of November 21, 2025). During the week of November 17 to November 21, De Magny Pharma's filing status was in the process of supplementary materials; Hao Te Energy, Shi Mai Pharma, Mairui Biology, Canopy Siasun Robot & Automation, De Feng Technology and other companies planned to launch IPO in Hong Kong and received materials accepted by the China Securities Regulatory Commission; UBOX ONLINE (02429), Yao Jie An Kang (02617), BAMA TEA (06980), INT MEDICAL (01501), LIANLIAN (02598) and other companies' share full circulation materials accepted by the China Securities Regulatory Commission.